Pharma Mar S.A. (PHMMF)
PNK: PHMMF
· Real-Time Price · USD
88.18
0.00 (0.00%)
At close: Apr 30, 2025, 8:00 PM
0.00% (1D)
| Bid | 81.83 |
| Market Cap | 1.55B |
| Revenue (ttm) | 175.75M |
| Net Income (ttm) | 19.88M |
| EPS (ttm) | 1.28 |
| PE Ratio (ttm) | 68.89 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 88.18 |
| Volume | 100 |
| Avg. Volume (20D) | 39 |
| Open | 105.60 |
| Previous Close | 88.18 |
| Day's Range | 88.18 - 105.60 |
| 52-Week Range | 26.85 - 105.60 |
| Beta | 0.06 |
About PHMMF
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ov...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 23, 2016
Employees 500
Stock Exchange PNK
Ticker Symbol PHMMF
Website https://www.pharmamar.com